Back to Search
MICHAEL ROTHENBERG, M.D., PH.D.
M.D., PH.D.
Gastroenterology Physician
NPI: 1306014071Individual
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
A96368(CA)
Research & Publications (20)
Successful use of octreotide to treat Ménétrier's disease: a rare cause of abdominal pain, weight loss, edema, and hypoalbuminemia.
PMID 19255847·Dig Dis Sci·2009
5-case
Antibiotics in the management of hepatic encephalopathy: an evidence-based review.
PMID 17713457·Rev Gastroenterol Disord·2005
6-review
Voice onset time versus articulatory modeling for stop consonants.
PMID 19513923·Logoped Phoniatr Vocol·2009
8-other
Molecular diagnostics and treatment of patients with the hypereosinophilic syndrome.
PMID 19274040·Clin Adv Hematol Oncol·2009
8-other
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study.
PMID 18550577·Ann Oncol·2008
3-trial
Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
PMID 18344568·N Engl J Med·2008
4-observational
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma.
PMID 16361624·J Clin Oncol·2005
3-trial
Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study.
PMID 15581954·Gynecol Oncol·2004
3-trial
Current status of second-line therapy for metastatic colorectal cancer.
PMID 15212701·Clin Colorectal Cancer·2004
6-review
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.
PMID 12775730·J Clin Oncol·2003
3-trial
Drosophila pod-1 crosslinks both actin and microtubules and controls the targeting of axons.
PMID 12948445·Neuron·2003
7-preclinical
Improving the evaluation of new cancer treatments: challenges and opportunities.
PMID 12671669·Nat Rev Cancer·2003
6-review
Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial.
PMID 12663720·J Clin Oncol·2003
3-trial
Current status of capecitabine in the treatment of colorectal cancer.
PMID 12520635·Oncology (Williston Park)·2002
6-review
Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study.
PMID 12377645·Ann Oncol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 PASTEUR DRIVE, ALWAY BUILDING M211, MC5187
STANFORD, CA 94305 - Phone
- (650) 725-3362
Quick Facts
- NPI
- 1306014071
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile